Jason Roszik

Jason Roszik

UNVERIFIED PROFILE

Are you Jason Roszik?   Register this Author

Register author
Jason Roszik

Jason Roszik

Publications by authors named "Jason Roszik"

Are you Jason Roszik?   Register this Author

91Publications

3193Reads

22Profile Views

TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.

Cancer Immunol Immunother 2019 Sep 9. Epub 2019 Sep 9.

Department of Oncology, Sackler Faculty of Medicine, Tel Aviv University, 6997801, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02382-0DOI Listing
September 2019

Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.

Cancer Immunol Immunother 2019 Sep 12. Epub 2019 Sep 12.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02385-xDOI Listing
September 2019

Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets.

Cancers (Basel) 2019 Aug 31;11(9). Epub 2019 Aug 31.

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11091283DOI Listing
August 2019

Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer.

Am J Cancer Res 2019 1;9(8):1830-1845. Epub 2019 Aug 1.

Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726999PMC
August 2019

Drugging the R-loop interactome: RNA-DNA hybrid binding proteins as targets for cancer therapy.

DNA Repair (Amst) 2019 Jul 6:102642. Epub 2019 Jul 6.

MTA-DE Momentum, Genome Architecture and Recombination Research Group, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dnarep.2019.102642DOI Listing
July 2019

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma.

Cancers (Basel) 2019 Jun 20;11(6). Epub 2019 Jun 20.

Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11060856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628316PMC
June 2019

mTOR at the Transmitting and Receiving Ends in Tumor Immunity.

Front Immunol 2018 27;9:578. Epub 2018 Mar 27.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.00578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890199PMC
May 2019

The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth.

Pigment Cell Melanoma Res 2019 03 16;32(2):303-314. Epub 2018 Dec 16.

Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12751DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613776PMC
March 2019

The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma.

Clin Cancer Res 2019 Mar 11;25(5):1650-1663. Epub 2018 Dec 11.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397703PMC
March 2019

Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma.

Case Rep Oncol 2019 Jan-Apr;12(1):7-13. Epub 2019 Jan 4.

Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000496018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381925PMC
January 2019

High-Throughput Architecture for Discovering Combination Cancer Therapeutics.

JCO Clin Cancer Inform 2018 12;2:1-12

Matt Gianni, Geert Wenes, and Becca Bandstra, Cray Inc, Seattle, WA; Yong Qin, Anthony P. Conley, Vivek Subbiah, Suhendan Ekmekcioglu, Elizabeth A. Grimm, and Jason Roszik, The University of Texas MD Anderson Cancer Center, Houston, TX; and Raya Leibowitz-Amit, Tel Aviv University Sackler School of Medicine, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/CCI.17.00054
Publisher Site
http://dx.doi.org/10.1200/CCI.17.00054DOI Listing
December 2018

Reply to Oegema et al.: CFI-400945 and Polo-like kinase 4 inhibition.

Proc Natl Acad Sci U S A 2018 11 30;115(46):E10810-E10811. Epub 2018 Oct 30.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1813967115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243257PMC
November 2018

Commentary: Nuclear dynamics of the Set1C subunit Spp1 prepares meiotic recombination sites for break formation.

Front Genet 2018 23;9:496. Epub 2018 Oct 23.

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2018.00496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206171PMC
October 2018

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report.

J Glob Oncol 2018 09 6;4:1-6. Epub 2017 Jul 6.

Anthony P. Conley, Van Anh Trinh, Chrystia M. Zobniw, Kristi Posey, Wei-Lien Wang, Alexander J. Lazar, Neeta Somaiah, Jason Roszik, and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX; Jaime D. Martinez, Universidad Nacional Autonoma de Mexico; and Oscar G. Arrieta, Instituto Nacional de Cancerologia, Mexico City, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2017.009993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180844PMC
September 2018

Editorial: Targeting Metabolism in Cancer Immunotherapy.

Front Immunol 2018 11;9:2029. Epub 2018 Sep 11.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.02029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141691PMC
September 2018

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.

Front Immunol 2018 19;9:2102. Epub 2018 Sep 19.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2018.02102
Publisher Site
http://dx.doi.org/10.3389/fimmu.2018.02102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156434PMC
September 2018

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers.

Mol Cancer Ther 2018 07 13;17(7):1595-1601. Epub 2018 Apr 13.

Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-1107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310221PMC
July 2018

Mining Public Databases for Precision Oncology.

Trends Cancer 2018 07 22;4(7):463-465. Epub 2018 May 22.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2018.04.008DOI Listing
July 2018

Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy.

Front Immunol 2018 16;9:1591. Epub 2018 Jul 16.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.01591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054965PMC
July 2018

Analysis of Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies.

JCO Precis Oncol 2018 13;2018. Epub 2018 Jul 13.

University of California, San Diego, Moores Cancer Center, La Jolla.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106866PMC
http://dx.doi.org/10.1200/PO.17.00235DOI Listing
July 2018

Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.

Ann Thorac Surg 2018 06 3;105(6):1621-1626. Epub 2018 Mar 3.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2018.01.081DOI Listing
June 2018

Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.

Curr Oncol Rep 2018 03 26;20(5):37. Epub 2018 Mar 26.

Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0668-zDOI Listing
March 2018

Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy.

Front Oncol 2018 16;8:67. Epub 2018 Mar 16.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864849PMC
March 2018

Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target.

Cancer Res 2018 02 17;78(3):587-592. Epub 2018 Jan 17.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-1752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080720PMC
February 2018

mTORC2 Promotes Tumorigenesis via Lipid Synthesis.

Cancer Cell 2017 Dec;32(6):807-823.e12

Biozentrum, University of Basel, 4056 Basel, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.11.011DOI Listing
December 2017

Recent advances in genomic profiling of adenosquamous carcinoma of the pancreas.

J Pathol 2017 11 25;243(3):271-272. Epub 2017 Sep 25.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4959DOI Listing
November 2017

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.

Curr Oncol Rep 2017 Oct 13;19(12):78. Epub 2017 Oct 13.

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0641-2DOI Listing
October 2017

A tool for discovering drug sensitivity and gene expression associations in cancer cells.

PLoS One 2017 28;12(4):e0176763. Epub 2017 Apr 28.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176763PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409143PMC
September 2017

In Silico Restriction Enzyme Digests to Minimize Mapping Bias in Genomic Sequencing.

Mol Ther Methods Clin Dev 2017 Sep 24;6:66-67. Epub 2017 Jun 24.

MTA-DE Momentum, Genome Architecture and Recombination Research Group, Research Centre for Molecular Medicine, University of Debrecen, Nagyerdei krt 98, Debrecen 4032, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omtm.2017.06.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485759PMC
September 2017

The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 08 25;12(8):1280-1287. Epub 2017 May 25.

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.05.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532070PMC
August 2017

Biophysical characterization of histone H3.3 K27M point mutation.

Biochem Biophys Res Commun 2017 08 21;490(3):868-875. Epub 2017 Jun 21.

MTA-DE Momentum, Genome Architecture and Recombination Research Group, Research Centre for Molecular Medicine, Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen 4032, Hungary. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2017.06.133DOI Listing
August 2017

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.

Clin Sarcoma Res 2017 15;7:11. Epub 2017 Jun 15.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13569-017-0077-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471883PMC
June 2017

Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.

Front Immunol 2017 16;8:689. Epub 2017 Jun 16.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.00689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473350PMC
June 2017

The potential role of platelets in the consensus molecular subtypes of colorectal cancer.

Cancer Metastasis Rev 2017 06;36(2):273-288

Department of Gastrointestinal Medical Oncology, M. D. Anderson Cancer, Unit 0426, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10555-017-9678-9
Publisher Site
http://dx.doi.org/10.1007/s10555-017-9678-9DOI Listing
June 2017

Targeting iNOS to increase efficacy of immunotherapies.

Hum Vaccin Immunother 2017 05 25;13(5):1105-1108. Epub 2017 Jan 25.

a Department of Melanoma Medical Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21645515.2016.1276682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443387PMC
May 2017

Towards precision oncology in RET-aberrant cancers.

Cell Cycle 2017 05 20;16(9):813-814. Epub 2017 Mar 20.

a The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2017.1302235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444346PMC
May 2017

IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.

Cancer Immunol Res 2016 11 3;4(11):983-994. Epub 2016 Oct 3.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0195DOI Listing
November 2016

Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma.

Mol Cancer Ther 2016 10 25;15(10):2442-2454. Epub 2016 Jul 25.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079683PMC
http://dx.doi.org/10.1158/1535-7163.MCT-15-0963DOI Listing
October 2016

Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.

Cell 2016 Oct 22;167(2):397-404.e9. Epub 2016 Sep 22.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088716PMC
http://dx.doi.org/10.1016/j.cell.2016.08.069DOI Listing
October 2016

RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.

Oncotarget 2016 Jun;7(24):36711-36718

Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9164DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095033PMC
June 2016

Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression.

Pigment Cell Melanoma Res 2016 May 15;29(3):297-308. Epub 2016 Mar 15.

Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12455DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840087PMC
May 2016

NLRC5/MHC class I transactivator is a target for immune evasion in cancer.

Proc Natl Acad Sci U S A 2016 May 9;113(21):5999-6004. Epub 2016 May 9.

Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX 77843;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1602069113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889388PMC
May 2016

Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma.

Clin Cancer Res 2016 Jan 25;22(2):374-82. Epub 2015 Aug 25.

Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821426PMC
January 2016

Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.

Sci Rep 2016 Jan 20;6:19649. Epub 2016 Jan 20.

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep19649DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726397PMC
January 2016

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

Cancer Cell 2015 Oct 1;28(4):515-528. Epub 2015 Oct 1.

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108150030
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2015.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605878PMC
October 2015

Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.

Pigment Cell Melanoma Res 2015 May 23;28(3):357-9. Epub 2015 Mar 23.

Department of Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA; Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12345DOI Listing
May 2015

HotSpotter: efficient visualization of driver mutations.

BMC Genomics 2014 Dec 1;15:1044. Epub 2014 Dec 1.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 7455 Fannin St, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-15-1044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265503PMC
December 2014

Quantitative high-throughput single-cell cytotoxicity assay for T cells.

J Vis Exp 2013 Feb 2(72):e50058. Epub 2013 Feb 2.

Department of Chemical and Biomolecular Engineering, University of Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/50058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596999PMC
February 2013